Yunnan Botanee Bio-Technology Group Co Ltd (300957) — Capital Reinvestment Ratio
Yunnan Botanee Bio-Technology Group Co Ltd (300957) has a Capital Reinvestment Ratio of 0.23x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥125.55 Million) in capital expenditures (CN¥29.13 Million). See 300957 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Yunnan Botanee Bio-Technology Group Co Ltd Capital Reinvestment Ratio (2017–2025)
This chart tracks Yunnan Botanee Bio-Technology Group Co Ltd's Capital Reinvestment Ratio across 9 annual periods.
Annual Capital Reinvestment Ratio for Yunnan Botanee Bio-Technology Group Co Ltd (2017–2025)
Year-by-year Capital Reinvestment Ratio for Yunnan Botanee Bio-Technology Group Co Ltd from 2017 to 2025. For live market cap and broader valuation context, see Yunnan Botanee Bio-Technology Group Co L (300957) market capitalisation.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.49x | CN¥976.60 Million | CN¥482.99 Million | ▼ -9.2% |
| 2024 | 0.54x | CN¥694.87 Million | CN¥378.38 Million | ▲ +21.2% |
| 2023 | 0.45x | CN¥610.44 Million | CN¥274.28 Million | ▼ -2.2% |
| 2022 | 0.46x | CN¥769.45 Million | CN¥353.42 Million | ▲ +95.6% |
| 2021 | 0.23x | CN¥1.15 Billion | CN¥270.68 Million | ▲ +13.1% |
| 2020 | 0.21x | CN¥431.03 Million | CN¥89.45 Million | ▲ +75.2% |
| 2019 | 0.12x | CN¥514.92 Million | CN¥61.01 Million | ▼ -61.6% |
| 2018 | 0.31x | CN¥102.20 Million | CN¥31.56 Million | ▲ +359.1% |
| 2017 | 0.07x | CN¥202.44 Million | CN¥13.62 Million | — |